SDGR
Schrödinger, Inc.
SDGR lost money over the past year, so it has no meaningful PE right now.
SDGR Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Weak | |
| Unavailable |
SDGR's revenue is currently healthy, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
SDGR PE Valuation
SDGR has no meaningful PE right now: it lost money over the past year.
SDGR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Stable | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect SDGR's profitability to improve, with its earnings and revenue holding steady. However, they disagree widely on these estimates.
SDGR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.78 | +$1.63 |
| Q2 2026 | -$0.73 | +$1.75 |
| Q1 2026 | -$1.40 | +$1.23 |
| Q4 2025 | -$1.41 | +$1.16 |
| Q3 2025 | -$2.41 | +$0.02 |
| Q2 2025 | -$2.48 | +$0.29 |
| Q1 2025 | -$2.63 | -$0.66 |
| Q4 2024 | -$2.57 | -576% |
SDGR is still losing money, but far less than before: $0.78 per share over the past year, against $2.77 at its worst in mid-2024.
SDGR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $64.5M | +19% |
| Q2 2026 | $58.9M | +7.5% |
| Q1 2026 | $58.6M | -1.6% |
| Q4 2025 | $87.2M | -1.2% |
| Q3 2025 | $54.3M | +54% |
| Q2 2025 | $54.8M | +16% |
| Q1 2025 | $59.6M | +63% |
| Q4 2024 | $88.3M | +19% |
SDGR's revenue is recovering but still below its 2024 peak: $64M last quarter, up 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -41% | +44 points |
| Q2 2026 | -71% | +26 points |
| Q1 2026 | -83% | +2.2 points |
| Q4 2025 | -20% | +3.8 points |
| Q3 2025 | -85% | +109 points |
| Q2 2025 | -97% | +15 points |
| Q1 2025 | -85% | +99 points |
| Q4 2024 | -23% | +17 points |
SDGR's operating margin was −41% last quarter, up 44 points from the same quarter a year ago.
SDGR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$48.9M | +$13.5M |
| Q2 2026 | -$34.4M | +$18.1M |
| Q1 2026 | -$17.3M | -112% |
| Q4 2025 | -$16.1M | +$15.9M |
| Q3 2025 | -$62.4M | -$27.8M |
| Q2 2025 | -$52.5M | +$2.2M |
| Q1 2025 | $143.5M | +$186.8M |
| Q4 2024 | -$32M | +$7.7M |
SDGR has burned cash in almost every quarter: −$117M over the past year, against −$3M the year before.
SDGR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.2% | -904K shares |
| 1 year | +1.7% | +1.3M shares |
| 3 years | +4.1% | +2.9M shares |
| 5 years | +5.8% | +4.1M shares |
| Available history | +54% | +26.4M shares |
SDGR has 75M diluted shares, up 1.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
SDGR Net Leverage
SDGR's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
SDGR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.5 | Neutral |
| Stochastic | 75.2 | Neutral |
SDGR's weekly RSI is 69 (neutral) and its Stochastic is 75 (neutral).
SDGR PE vs Healthcare Sector
| Metric | SDGR | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
SDGR has no meaningful PE right now: it lost money over the past year.
SDGR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.6 | 12% above |
| 20 week MA | $22.1 | 39% above |
| 50 week MA | $17.4 | 77% above |
| 100 week MA | $19.3 | 60% above |
| 200 week MA | $23.4 | 32% above |
SDGR has climbed back above all five of its weekly moving averages, and it's now 32% above its 200-week average.
SDGR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $31.9 | $84.0 | +163% |
| 2021 | $84.0 | $35.9 | -57% |
| 2022 | $35.9 | $18.9 | -47% |
| 2023 | $18.9 | $35.8 | +90% |
| 2024 | $35.8 | $19.8 | -45% |
| 2025 | $19.8 | $18.3 | -7.4% |
| 2026 YTD | $18.3 | $30.9 | +68% |
SDGR's yearly returns have swung widely, from +163% in 2020 to −57% in 2021. It's up 68% so far in 2026.